Nadia de la Houssaye is co-leader of the firm's healthcare litigation team and chairs the Healthcare Industry telemedicine team. She works extensively with hospitals, health systems, providers, and start-up companies to structure and integrate telemedicine, telehealth, and digital health platforms.
Nadia has a broad-based litigation and healthcare regulatory practice advising clients from across the industry spectrum. Drawing on her more than 25 years in private practice and her firsthand experience as co-founder of and general counsel to one of Louisiana’s first teleradiology networks, Nadia helps clients navigate the rapidly developing regulatory landscape affecting today’s healthcare delivery, including US Food and Drug Administration (FDA) application and registration processes and Emergency Use Authorization (EUA) approvals, US Centers for Medicare & Medicaid Services (CMS) coverage issues, state corporate practice of medicine regulations, and issues arising during the COVID-19 era and beyond. She also helps hospitals, health systems, physician practice groups, and other providers manage the full range of traditional healthcare matters, including medical malpractice defense, hospital-physician relations, licensing and credentialing, and risk management.
Among recent client matters, Nadia advised a leading laboratory services company on all aspects of its successful EUA application for a polymerase chain reaction-based (PCR) test for SARS-CoV-2, the virus that causes COVID-19. She also advised a national provider of in-home healthcare services on FDA compliance mandates related to the importing of personal protective equipment (PPE), and has been a leading voice helping providers understand and comply with updated federal and state guidance on the use of telemedicine in a broad range of medical specialties in the effort to limit the spread of COVID-19.
